Potential treatment for subthreshold and mild depression: A comparison of St. John's wort extracts and fluoxetine
- 1 March 2000
- journal article
- research article
- Published by Elsevier in Comprehensive Psychiatry
- Vol. 41 (2) , 133-137
- https://doi.org/10.1016/s0010-440x(00)80019-x
Abstract
No abstract availableKeywords
This publication has 7 references indexed in Scilit:
- St. John's Wort in Mild to Moderate Depression: The Relevance of Hyperforin for the Clinical EfficacyPharmacopsychiatry, 1998
- Hypericum treatment of mild-moderate depression in a placebo-controlled study. A prospective, double-blind, randomized, placebo-controlled, multicentre studyHuman Psychopharmacology: Clinical and Experimental, 1998
- Efficacy and Tolerability of St. John's Wort Extract LI 160 Versus Imipramine in Patients with Severe Depressive Episodes According to ICD-10Pharmacopsychiatry, 1997
- LI 160, an Extract of St. John's Wort, Versus Amitriptyline in Mildly to Moderately Depressed Outpatients - A Controlled 6-Week Clinical TrialPharmacopsychiatry, 1997
- St John's wort for depression--an overview and meta-analysis of randomised clinical trialsBMJ, 1996
- A Double-blind Comparative Study of Fluoxetine and Dothiepin in the Treatment of Depression in General PracticeInternational Clinical Psychopharmacology, 1989
- The Hamilton Rating Scale for depression: a factor analysisPsychological Medicine, 1972